Today, NVIDIA has announced UK’s most powerful supercomputer, the Cambridge-1. Scientists and healthcare experts can utilize the deadly combo of AI and simulation to catalyze the digital biology revolution and support the country’s world-leading life sciences industry.
NVIDIA has put in a $100 million investment for Cambridge-1 and it unites NVIDIA’s decades of work in accelerated computing, AI, and life sciences as NVIDIA Clara and AI frameworks are optimized to utilize this huge system. It holds a place among the world’s top 50 fastest computers and is powered by 100 percent renewable energy.
The computer’s first project is in partnership with AstraZeneca, GSK, Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, and Oxford Nanopore Technologies where they develop a deeper understanding of brain diseases like dementia.
The computer will provide a platform for current and future generations to research and excel in science. In Fact, as per a report from an economics consulting firm, Frontier Economics, Cambridge-1 has the potential to create an estimated value of £600 million (about $825 million) over the next 10 years.
As far as the specifications are concerned, it has 80 DGX A100 systems that integrates NVIDIA A100 GPUs, BlueField -2 DPUs, and NVIDIA HDR InfiniBand networking. This NVIDIA DGX SuperPOD provides more than 400 petaflops of AI performance and 8 petaflops of Linpack performance. The system is located at a facility operated by NVIDIA partner Kao Data.